Synthesis and characterization of dendrimer-based polysarcosine star polymers: well-defined, versatile platforms designed for drug delivery applications.

This paper describes the synthesis of star polymers designed for future drug delivery applications. A generation-5 lysine dendrimer was used as a macroinitiator for the ring opening polymerization of sarcosine N-carboxyanhydride monomer to produce 32-arm star polymers with narrow molar mass distributions and desirable hydrodynamic size control. Fluorescent dye labeled polymers were dosed in mice to measure plasma pharmacokinetics. Long circulation times were observed, representing ideal properties for biophysical targeting of tumors. In vivo efficacy of one of these star polymers conjugated to the therapeutic molecule SN-38 was evaluated in mice bearing SW620 xenografted tumors to demonstrate high anti-tumor activity and low body weight loss compared to the SN-38 prodrug, irinotecan, and show the potential of these delivery systems. As a further build, we demonstrated that these star polymers can be easily chain-end functionalized with useful chemical moieties, giving opportunities for future receptor targeting strategies. Finally, we describe the synthetic advantages of these star polymers that make them attractive from a pharmaceutical manufacturing perspective and report characterization of the polymers with a variety of techniques.